A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

Part of paid clinical trials in Macon, Georgia.

Sponsor
Organon and Co
Study ID
NCT05789576
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an open-label, multi-center study to evaluate the efficacy and safety of VTAMA (tapinarof) cream, 1% in adults with plaque psoriasis occurring in the head and neck region

Key Dates

Start date
Mar 13, 2023
Status verified
Aug 2024
Primary completion
Jun 30, 2023
Completion
Jul 19, 2023

Study Design

Enrollment
31 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: VTAMA (tapinarof) cream, 1%
    VTAMA (tapinarof) cream, 1% applied topically once daily

Primary Outcome Measure

Percentage of Participants Who Achieve a Target Lesion Physician Global Assessment (PGA) Score in the Head and Neck Region of Clear (0) or Almost Clear (1) With a ≥ 2-grade Improvement [ Time Frame: from Baseline to Week 12 ]

Locations (10)

FacilityCityStateZIPSite coordinators
Dermavant Investigative SiteMaconGeorgia31217-
Dermavant Investigative SiteChicagoIllinois60602-
Dermavant Investigative SitesRockvilleMaryland20850-
Dermavant Investigative SiteAuburn HillsMichigan48326-
Dermavant Investigative SiteDetroitMichigan48202-
Dermavant Investigative SiteLas VegasNevada89144-
Dermavant Investigative SitePortsmouthNew Hampshire03801-
Dermavant Investigative SiteKew GardensNew York11415-
Dermavant Investigative SiteMarionOhio43302-
Dermavant Investigative SiteArlingtonTexas76014-

Find similar trials in Macon, GA

By condition

Related Studies